RSV Vaccine Market To Reach USD 2.2 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Fort Collins, Colorado, April 18, 2024 (GLOBE NEWSWIRE) -- Growing prevalence of RSV in the population drives the need for RSV vaccines. RSV, a prevalent respiratory virus, often leads to severe respiratory tract infections, particularly among vulnerable populations such as young children, the elderly, immune-compromised individuals, and infants. These infections vary in severity, ranging from mild cold-like symptoms to severe lower respiratory tract infections like pneumonia and bronchiolitis. In newborns and young children, RSV infections can necessitate hospitalization and admission to critical care units and, in some cases, can even result in fatalities, especially among preterm infants or those with underlying medical conditions. Moreover, RSV infections contribute significantly to hospitalizations, healthcare costs, and related challenges within the healthcare system. Recognizing RSV as a severe public health concern underscores the urgent need for effective prevention me
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]Yahoo! Finance
- 3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- NVAX's page on the SEC website